Sizzling update why Cleveland BioLabs, Inc. (CBLI) shares surged on Friday night

Cleveland BioLabs, Inc. (NASDAQ: CBLI) stock was tossed up almost 30% to $3.7 in the late hours on Friday after the reports that in connection with the merger of CBLI with Cytocom, the Lifshitz Law Firm, P.C. is investigating possible breaches of fiduciary duties. CBLI investors who wish to learn more about our investigation should complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at

Read More

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Most Popular

Related posts